Third Rock Ventures Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
46
- Investments
-
143
- Portfolio
-
30
- Exits
-
93
Third Rock Ventures General Information
Company Description
Founded in 2007, Third Rock Ventures is a venture capital firm based in Boston, Massachusetts. The firm seeks to invest in companies operating in the healthcare, medicine, life sciences, drugs, devices and diagnostics, therapeutics, and information technology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.thirdrockventures.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 201 Brookline Avenue
- Suite 1401
- Boston, MA 02215
- United States
Third Rock Ventures Investments (143)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Merida Biosciences | 08-Apr-2025 | Early Stage VC | Biotechnology | Pre-Clinical Trials | ||
| Maze Therapeutics | 26-Nov-2024 | Drug Discovery | Profitable | |||
| Trace Neuroscience | 12-Nov-2024 | Laboratory Services (Healthcare) | Generating Revenue | |||
| Seaport Therapeutics | 31-Oct-2024 | Drug Discovery | Pre-Clinical Trials | |||
| TRC 2004 | 13-Sep-2024 | Drug Discovery | Startup | |||
| Candid Therapeutics | 20-Aug-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Marea (Biotechnology) | 11-Jun-2024 | Biotechnology | Clinical Trials - Phase 1 | |||
| Septerna | 24-May-2024 | Drug Discovery | Generating Revenue/Not Profitable | |||
| AsherBio | 16-Apr-2024 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Seaport Therapeutics | 08-Apr-2024 | Early Stage VC | Drug Discovery | Pre-Clinical Trials |
Third Rock Ventures Exits (93)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Maze Therapeutics | 31-Jan-2025 | IPO | |
| Rheos Medicines | 26-Jan-2025 | ||
| PanOptica | 31-Dec-2024 | ||
| Septerna | 25-Oct-2024 | ||
| TRC 2004 | 09-Sep-2024 | ||
| Celsius Therapeutics | 27-Jun-2024 | ||
| Rapport Therapeutics | 07-Jun-2024 | ||
| Nurix Therapeutics | 12-Apr-2024 | ||
| Alcresta Therapeutics | 12-Mar-2024 | Buyout/LBO | |
| Cargo Therapeutics | 10-Nov-2023 | IPO |
Third Rock Ventures Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Third Rock Ventures Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Third Rock Ventures Co-Investors (140)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Casdin Capital | 7 |
|
|
||
| Alexandria Venture Investments |
|
|
|||
| GV |
|
|
|||
| Logos Capital |
|
|
|||
| T. Rowe Price Group |
|
|
Third Rock Ventures FAQs
-
What is Third Rock Ventures?
Founded in 2007, Third Rock Ventures is a venture capital firm based in Boston, Massachusetts.
-
When was Third Rock Ventures founded?
Third Rock Ventures was founded in 2007.
-
Where is Third Rock Ventures headquartered?
Third Rock Ventures is headquartered in Boston, MA.
-
What is Third Rock Ventures's total asset value?
Third Rock Ventures has around in total assets under management.
-
How many investments has Third Rock Ventures made?
Third Rock Ventures has made 143 investments.
-
What has Third Rock Ventures invested in?
Third Rock Ventures has made numerous investments in companies like Merida Biosciences, Maze Therapeutics, and Trace Neuroscience within the Biotechnology, Drug Discovery, and Laboratory Services (Healthcare) industries.
-
What has Third Rock Ventures invested in recently?
Third Rock Ventures's latest investment was on 08-Apr-2025 in Merida Biosciences, a company within the Biotechnology industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
